MIDAZOLAM ACCORD 5 mg/ml, solution injectable — 10 ampoule(s) en verre de 10 ml

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930233207
  • CIP7 3023320
  • CIS 68529120

What the source publishes

Holder
ACCORD HEALTHCARE FRANCE
Active ingredients
MIDAZOLAM, CHLORHYDRATE DE MIDAZOLAM
Form
solution injectable pour perfusion ou
Package
10 ampoule(s) en verre de 10 ml
Routes
intramusculaire, intraveineuse, rectale, sous-cutanée
Administrative status
authorised
Supply regime
prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée
Marketing status
Déclaration de commercialisation
Authorised on
2008-12-05
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930233207
{
  "cis": "68529120",
  "cip7": "3023320",
  "form": "solution injectable pour perfusion ou",
  "name": "MIDAZOLAM ACCORD 5 mg/ml, solution injectable — 10 ampoule(s) en verre de 10 ml",
  "cip13": "3400930233207",
  "holder": "ACCORD HEALTHCARE FRANCE",
  "routes": [
    "intramusculaire",
    "intraveineuse",
    "rectale",
    "sous-cutanée"
  ],
  "holders": [
    "ACCORD HEALTHCARE FRANCE"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "33.57",
  "authorisedOn": "2008-12-05",
  "compositions": [
    {
      "name": "MIDAZOLAM",
      "nature": "FT",
      "strength": "5 mg",
      "linkageNumber": "1",
      "substanceCode": "02667",
      "dosageReference": "1 ml de solution injectable",
      "pharmaceuticalElement": "solution"
    },
    {
      "name": "CHLORHYDRATE DE MIDAZOLAM",
      "nature": "SA",
      "strength": null,
      "linkageNumber": "1",
      "substanceCode": "51868",
      "dosageReference": null,
      "pharmaceuticalElement": "solution"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "prescription limitée à 4 semaines ; délivrance fractionnée de 7 jours ; liste I ; prescription en toutes lettres sur ordonnance sécurisée",
  "dispensingFee": "1.02",
  "medicinePrice": "32.55",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "MIDAZOLAM ACCORD 5 mg/ml, solution injectable",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "10 ampoule(s) en verre de 10 ml",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65 %"
  ],
  "marketingDeclaredOn": "2022-04-04",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "MIDAZOLAM",
    "CHLORHYDRATE DE MIDAZOLAM"
  ],
  "authorisationProcedure": "Procédure nationale",
  "prescriptionConditions": [
    "prescription limitée à 4 semaines",
    "délivrance fractionnée de 7 jours",
    "liste I",
    "prescription en toutes lettres sur ordonnance sécurisée"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": null,
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930233207"